From: Michelle Younis [myounis@epixmed.com]
Sent: Thursday, November 14, 2002 12:50 AM
To: FDADockets@oc.fda.gov
Subject: ATTENDANCE REQUEST FOR NOV 25 COMBINATION PRODUCTS PUBLIC HEARING

Dockets Management Branch Administrator,


Good morning. I would like to add Susan Flint, VP of Regulatory Affairs and Clinical Operations at EPIX Medical, Inc. to the participant list of the Nov 25 FDA Regulation of Combination Products; Public Hearing. I realize that the Federal Register stated that all participation requests be submitted by Nov 8 we were just notified of this hearing. She is very anxious to attend this meeting so I hope there is still space available.

Please email me with a confirmation as soon as possible so that I may add this to her calendar and make the necessary travel arrangements.


I look forward to your response and thank you for your attention to this matter.


Regards,


Michelle Younis


*********************************

Michelle Younis

Administrator

Clinical & Regulatory Dept

EPIX Medical Inc.

71 Rogers Street

Cambridge, MA 02142

Ph: 617-250-6016

Fax: 617-250-6033

Email: myounis@epixmed.com

**********************************

STATEMENT OF CONFIDENTIALITY

The information contained in this electronic message and any attachment(s) to this message are intended for the exclusive use of the addressee(s) and may contain confidential or proprietary information protected under federal, state or other applicable law. Any review, use, disclosure, copying, distribution or taking of any action in reliance of this electronic message or its attachment(s) that is not authorized in writing by EPIX Medical, Inc. is strictly prohibited. If you are not

the intended recipient or an authorized representative of the intended recipient, please notify the sender immediately by return email and delete all copies of this electronic message and any attachment(s) from your system. Thank you for your cooperation.